Bill114th CongressFiled Nov 17, 2016Health
H.R. 6348
To extend for two years the program for priority review to encourage treatments for rare pediatric diseases.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Nov 17, 2016)
This bill amends the Federal Food, Drug, and Cosmetic Act to extend through 2018 the priority review voucher program for treatments for rare pediatric diseases. (A priority review voucher is a transferable voucher that entitles the holder to have a new drug or biological product application acted upon by the Food and Drug Administration within six months.)
What just happenedNov 17, 2016
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Grayson, Alan [D-FL-9](D-FL)Sponsor
1committees3actions1related bills
- Introduced in HouseNov 17, 2016
- Nov 17, 2016IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Nov 17, 2016IntroReferralIntro-H
Introduced in House
- Nov 17, 2016IntroReferral1000
Introduced in House